Presentation is loading. Please wait.

Presentation is loading. Please wait.

Top panel: AUC0–31h of M1 and glargine in the nine individual subjects (M1, open circles; glargine, filled circles) and median and 10th, 25th, 75th, and.

Published byMagdalene Webster Modified over 5 years ago

Similar presentations

Presentation on theme: "Top panel: AUC0–31h of M1 and glargine in the nine individual subjects (M1, open circles; glargine, filled circles) and median and 10th, 25th, 75th, and."— Presentation transcript:

1 Top panel: AUC0–31h of M1 and glargine in the nine individual subjects (M1, open circles; glargine, filled circles) and median and 10th, 25th, 75th, and 90th percentiles AUC0–31h in the group of M1 (open box) and glargine (hatched box) (top left panel) and Cmax of M1 (open circles) and glargine (filled circles) in individual subjects and median and 10th, 25th, 75th, and 90th percentiles Cmax in the group of M1 (open box) and glargine (hatched box) (top right panel). Top panel: AUC0–31h of M1 and glargine in the nine individual subjects (M1, open circles; glargine, filled circles) and median and 10th, 25th, 75th, and 90th percentiles AUC0–31h in the group of M1 (open box) and glargine (hatched box) (top left panel) and Cmax of M1 (open circles) and glargine (filled circles) in individual subjects and median and 10th, 25th, 75th, and 90th percentiles Cmax in the group of M1 (open box) and glargine (hatched box) (top right panel). Bottom panel: individual values of AUC0–31h of M1 and glargine (LC-MS/MS) (bottom left panel) and Cmax of M1 and glargine (M1 open columns; glargine, hatched columns) in the nine subjects. Paola Lucidi et al. Dia Care 2012;35: ©2012 by American Diabetes Association

Download ppt "Top panel: AUC0–31h of M1 and glargine in the nine individual subjects (M1, open circles; glargine, filled circles) and median and 10th, 25th, 75th, and."

Similar presentations

Examining the top three rows first Row two requires a 5. It has to be located in the middle 3x3 box. Two possible locations for 5 in centre box The centre.

Examining the top three rows first Row two requires a 5. It has to be located in the middle 3x3 box. Two possible locations for 5 in centre box The centre.
Lattice Multiplication. Step 1 1)Draw a set of 2 by 2 boxes. 46 x 79 2) Cut the boxes in half diagonally. 3) Place the numbers on the outside of the boxes.

Lattice Multiplication. Step 1 1)Draw a set of 2 by 2 boxes. 46 x 79 2) Cut the boxes in half diagonally. 3) Place the numbers on the outside of the boxes.
Copyright © American Speech-Language-Hearing Association

Copyright © American Speech-Language-Hearing Association
A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.

A: Box plot comparing the average changes in HbA1c between surgery and medical/lifestyle treatments in the first reports of the 11 RCTs published to date.
A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.

A: Percentage of type 1 diabetic and type 2 diabetic patients with asymptomatic hypoglycemias detected by the CGMS. B: Daily distribution of asymptomatic.
Plasma active glucagon-like peptide-1 (GLP-1) response in patients with type  2 diabetes during the liquid high-fat meal test at baseline, 12 weeks and.

Plasma active glucagon-like peptide-1 (GLP-1) response in patients with type  2 diabetes during the liquid high-fat meal test at baseline, 12 weeks and.
Insulin and glucagon secretion: nondiabetic and diabetic subjects.

Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Differences in the glycated hemoglobin (HbA1c) levels.

Differences in the glycated hemoglobin (HbA1c) levels.
Graph (box plots) shows primary tumor volumes of oral and maxillary sinus (A) and pharyngeal (B) cancers categorized at T1–T4. Graph (box plots) shows.

Graph (box plots) shows primary tumor volumes of oral and maxillary sinus (A) and pharyngeal (B) cancers categorized at T1–T4. Graph (box plots) shows.
Divide the paper into three sections.

Divide the paper into three sections.
Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.

Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.
Categorisation of subjects in four groups according to median values of left ventricular end-diastolic volume (LVEDV) mL/m2 and E/e′. Categorisation of.

Categorisation of subjects in four groups according to median values of left ventricular end-diastolic volume (LVEDV) mL/m2 and E/e′. Categorisation of.
19 27 4 1. This is an Arithmagon….

This is an Arithmagon….
Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.

Box plots showing the relative difference in distribution of mtDNA copy number per cell between patients with ESRD and healthy control subjects frequency.
Between-country and within-country variability in the number of nursing care activities left undone—composite score in 488 European hospitals. Between-country.

Between-country and within-country variability in the number of nursing care activities left undone—composite score in 488 European hospitals. Between-country.
Number of neonates with BPD-PH per hospital and the number of neonates per hospital who received sildenafil. Number of neonates with BPD-PH per hospital.

Number of neonates with BPD-PH per hospital and the number of neonates per hospital who received sildenafil. Number of neonates with BPD-PH per hospital.
Median percentage weight change (left panels) and median weight (right panels) by birth weight groups as a function of time after (A) vaginal delivery.

Median percentage weight change (left panels) and median weight (right panels) by birth weight groups as a function of time after (A) vaginal delivery.
Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs7903146 polymorphism and the dietary intervention group after.

Incidence rates and HRs for total cardiovascular events and stroke stratified by the TCF7L2-rs polymorphism and the dietary intervention group after.
The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.

The rates of occurrences of cardiovascular, cerebrovascular, and all events expressed in cases per 1, 000 patient-years in diabetic subgroups divided by.
Trends in prevalence of diabetes in middle-aged women grouped according to BMI at the first survey of the ALSWH. ▪, healthy (n = 5,252); ♦, overweight.

Trends in prevalence of diabetes in middle-aged women grouped according to BMI at the first survey of the ALSWH. ▪, healthy (n = 5,252); ♦, overweight.

Similar presentations

Ads by Google